Randox Toxicology - Blog
- The global drug market is growing at a rapid rate with multiple drugs emerging incessantly. The advancement of biochip technology has enabled Randox Toxicology to create pioneering developments to stay ahead of this ever changing market.February 15, 2018
- Randox Toxicology’s latest series, Biochip Vs ELISA highlights our routine and novelELISA products and how they differ from Biochip Array Technology. Showcasing our journey and ongoing brand evolution, discover which method is right for you!February 13, 2018
- Enzyme-linked immunosorbent assay, or ELISA, has been utilised as a screening tool for some time. The immunoassay technique is a popular choice for the evaluation of various research and diagnostic targets including drugs ofFebruary 1, 2018
There are no upcoming events.